Pharmaceutical - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

101 to 125 of 650 results

Pharma and biotech sector leads the way in global M&A deals

Pharma and biotech sector leads the way in global M&A deals

20-06-2014

The pharma, medical and biotech industry is the most active sector for mergers and acquisitions so far…

BiotechnologyEuropeMergers & AcquisitionsPharmaceutical

SillaJen changes its name to mark Jennerex acquisition

20-06-2014

South Korean privately held pharma company SillaJen has changed its name to SillaJen Biotherapeutics…

Asia-PacificJennerexManagementMergers & AcquisitionsOncologyPexa-VecPharmaceuticalSillaJen

Shire rejects unsolicited $46.5 billion takeover offer from AbbVie

Shire rejects unsolicited $46.5 billion takeover offer from AbbVie

20-06-2014

Ireland headquartered Shire has this morning revealed that it has received, and rejected, an unsolicited…

AbbVieMergers & AcquisitionsPharmaceuticalShire

European Commission approves JV between Fresenius and Sistema

European Commission approves JV between Fresenius and Sistema

19-06-2014

The European Commission has cleared under the EU Merger Regulation the creation of a joint venture between…

AFK SistemaFreseniusLegalMergers & AcquisitionsPharmaceuticalRussia

Pfizer inks multi-million $ cancer immunology deal with Cellectis

Pfizer inks multi-million $ cancer immunology deal with Cellectis

18-06-2014

France-based genome engineering specialist Cellectis saw its shares rocket nearly 50% to 9.26 euros,…

CellectisLicensingMergers & AcquisitionsOncologyPfizerPharmaceutical

Valeant goes hostile in $53 billion bid for Allergan

Valeant goes hostile in $53 billion bid for Allergan

18-06-2014

Canada’s Valeant Pharmaceuticals International has today commenced an exchange offer for the common…

AllerganMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Medtronic in $42.9 billion deal to acquire Covidien

Medtronic in $42.9 billion deal to acquire Covidien

16-06-2014

US medical technology and services company Medtronic has inked a definitive agreement to acquire Dublin,…

CovidienMedtronicMergers & AcquisitionsPharmaceutical

Pershing Square files law suit over Allergan’s rights plan

Pershing Square files law suit over Allergan’s rights plan

15-06-2014

William Ackman's Pershing Square Capital Management has filed a law suit in the Delaware Court of Chancery…

AllerganLegalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Pharma more optimistic about future despite upcoming industry consolidation

Pharma more optimistic about future despite upcoming industry consolidation

13-06-2014

More than 69% of senior players within the pan-world pharma industry expect to see a year-on-year increase…

FinancialGlobalMergers & AcquisitionsPharmaceutical

Decision Resources Group analyst’s view on Merck’s decision to acquire Idenix

Decision Resources Group analyst’s view on Merck’s decision to acquire Idenix

12-06-2014

Given the huge potential, and interest in, the hepatitis treatment market, and US pharma giant Merck…

Anti-viralsIdenix PharmaceuticalsMerck & CoMergers & AcquisitionsPharmaceutical

Allergan board again rejects revised unsolicited takeover bid from Valeant

Allergan board again rejects revised unsolicited takeover bid from Valeant

10-06-2014

US Botox-maker Allergan says that its board of directors, after consulting with its independent financial…

AllerganMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Celsion to acquire nucleic acid-based therapeutics firm EGEN

Celsion to acquire nucleic acid-based therapeutics firm EGEN

10-06-2014

US cancer drug developer Celsion Corp has entered into a definitive asset purchase agreement with EGEN,…

CelsionEGENMergers & AcquisitionsOncologyPharmaceutical

Allergan warns shareholders to take no action ahead of Valeant calling ‘special meeting’

Allergan warns shareholders to take no action ahead of Valeant calling ‘special meeting’

03-06-2014

Takeover target USA-based Allergan has responded to action taken by Canadian drugmaker Valeant Pharmaceuticals…

AllerganBusiness FinanceMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Endo completes sale of early-stage drug discovery portfolio

Endo completes sale of early-stage drug discovery portfolio

02-06-2014

Ireland-headquartered Endo Pharmaceuticals has completed the sale of its branded pharmaceutical drug…

AsanaBioSciencesEndo PharmaceuticalsMergers & AcquisitionsPharmaceutical

Roche to acquire Genia Technologies for up to $350 million

Roche to acquire Genia Technologies for up to $350 million

02-06-2014

Swiss drug major Roche said this morning that it plans to acquire Genia Technologies, a privately held…

Genia TechnologiesMergers & AcquisitionsPharmaceuticalRoche

Valeant goes even further, upping recently sweetened offer for Allergan

Valeant goes even further, upping recently sweetened offer for Allergan

02-06-2014

Even before it received an official response from its takeover target US Botox-maker Allergan, acquisitive…

AllerganMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Forest appeases shareholders over Actavis deal

30-05-2014

US drugmaker Forest Laboratories has reached a settlement with shareholders over its deal with generics…

ActavisBusinessBusiness FinanceEnvironmentForest LaboratoriesMajorMergers & AcquisitionsNew York Stock ExchangePharmaceuticalUSA

In Focus: Strong drivers will keep the pharma M&A pipeline bubbling

In Focus: Strong drivers will keep the pharma M&A pipeline bubbling

28-05-2014

The record start to 2014’s pharma M&A has been a welcome boost to a deal market that had been in the…

CancerGlobalInterviewsMergers & AcquisitionsPfizerPharmaceuticalPharmaceutical industryPharmaceutical sciences

Valeant ups offer for Allergan as target publishes attack on its business model

Valeant ups offer for Allergan as target publishes attack on its business model

28-05-2014

Canadian drugmaker Valeant Pharmaceuticals International has today upped its offer for USA-based Allergan…

AllerganBusiness FinanceBusiness FinanceCanadaMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

28-05-2014

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International has entered into an agreement to…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceuticalValeant Pharmaceuticals

Is outsourcing the solution to the practical and business challenges facing pharma firms today?

Is outsourcing the solution to the practical and business challenges facing pharma firms today?

27-05-2014

Mergers and acquisitions within the pharmaceutical industry are nothing new, writes Alan Cox, chief executive…

AstraBusinessHealth Medical PharmaInterviewsMergers & AcquisitionsPharmaceuticalPharmaceutical sciencesPharmacology

AstraZeneca safe (for now?) as Pfizer walks away from pursuit of the firm

26-05-2014

US pharma giant Pfizer, which has been involved in a controversial pursuit of UK-based AstraZeneca, has…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

101 to 125 of 650 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top